Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmAsia News Australia/New Zealand Roundup: Medicines Australia, PHARMAC, Helicon, Pharmaxis

This article was originally published in PharmAsia News

Executive Summary

Medicines Australia Critical Of Labor Government's First Budget

You may also be interested in...



Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotechs In 2009 Budget

“This will be the first time in 21 years that there will be no dedicated industry support program to promote investment in this valuable knowledge-based industry,” Medicines Australia exec warns..

Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotechs In 2009 Budget

“This will be the first time in 21 years that there will be no dedicated industry support program to promote investment in this valuable knowledge-based industry,” Medicines Australia exec warns..

Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotech In 2009 Budget

PERTH, Australia - The Australian federal 2009-2010 budget announced May 12, delivered a mixed bag to pharmaceutical and biotech companies, with biotech companies praising the R&D tax credit and Big Pharma critical of cuts to the Pharmaceutical Benefits Scheme

Related Content

UsernamePublicRestriction

Register

LL1130096

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel